Picture of DarioHealth logo

DRIO — DarioHealth News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

DarioHealth Corp reports results for the quarter ended in June - Earnings Summary

* DarioHealth Corp  DRIO.OQ  reported a quarterly adjusted
loss
of 74 cents​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 71 cents per share.
    * Revenue rose 17.5% to $6.18 million from a year ago;
analysts
expected $8.24 million. 
    * DarioHealth Corp's reported EPS for the quarter was a loss
of 82
cents​.
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * DarioHealth Corp shares had risen by 16.6% this
quarter and
lost 44.8% so far this year.
    * The company reported a quarterly loss of $18.46 million.
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 12:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.71          -0.74          Missed
 Mar. 31 2022      -0.96          -0.74          Beat
 Dec. 31 2021      -1.06          -1.09          Missed
 Sep. 30 2021      -0.94          -1.18          Missed

Recent news on DarioHealth

See all news